IRVINE, Calif., May 11, 2016 /PRNewswire/ -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in patient-focused
innovations for structural heart disease and critical care
monitoring, today announced that reports from its philanthropic
partners in the Every Heartbeat Matters initiative demonstrate they
have impacted the global burden of heart valve disease by
educating, screening and/or treating more than 200,000 underserved
individuals since the initiative launched in 2014.
"While heart valve disease is debilitating and life threatening,
with timely and appropriate care, people can not only survive, but
also live fulfilling and productive lives," said Michael A. Mussallem, chairman and CEO, Edwards
Lifesciences. "Every Heartbeat Matters is focused on reaching one
million underserved people and saving lives that would otherwise be
lost, by working with strategic partners to provide broad-reaching
public education, targeted heart screenings, advanced clinical
skill trainings, and treatment for some in desperate
circumstances."
Every Heartbeat Matters supports patient-focused non-profit
organizations through grants from Edwards Lifesciences Foundation
and donations of Edwards products for indigent care. The initiative
is focused on meeting one specific goal: by 2020, Every Heartbeat
Matters will impact the global burden of heart valve disease by
supporting the education, screening and treatment of one million
underserved people. Investments in this initiative to date total
more than $10 million.
"We are proud of the work that our non-profit partners are
leading to help some of the world's most disadvantaged heart valve
patients," said Mussallem. "We are inspired by their work and the
lives that have been improved already as we pursue our goal – yet
we also recognize that there is more work to be done."
Request for Proposals
Edwards Lifesciences Foundation
is seeking requests for funding from non-profit organizations
around the world to serve as partners on programs for the Every
Heartbeat Matters initiative and to strengthen the communities in
which Edwards' employees live and work. The foundation's 2016 grant
cycle will be open May 23 to June 17,
2016. Funding applications will be available at
Edwards.com/CorporateGiving. Additional information about Edwards'
global corporate giving, including a complete listing of all grants
issued from the foundation and information for potential partners,
can also be found on the website.
About Edwards Lifesciences and Edwards Lifesciences
Foundation
Edwards Lifesciences, based in Irvine,
Calif., is the global leader in patient-focused medical innovations
for structural heart disease, as well as critical care and surgical
monitoring. Driven by a passion to help patients, the company
collaborates with the world's leading clinicians and researchers to
address unmet healthcare needs, working to improve patient outcomes
and enhance lives. For more information, visit
www.Edwards.com and follow us on Twitter @EdwardsLifesci. In
2004, the company established what is now Edwards Lifesciences
Foundation. The foundation focuses on supporting underserved heart
valve and critically ill patients, as well as strengthening the
communities in which Edwards employees live and work. Since its
inception, the foundation has gifted more than $40 million to non-profit organizations.
Additional information can be found at
Edwards.com/CorporateGiving.
Edwards, Edwards Lifesciences, the stylized E logo and Every
Heartbeat Matters are trademarks of Edwards Lifesciences
Corporation. All other trademarks are the property of their
respective owners.
Logo - http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/edwards-lifesciences-philanthropy-impacts-200000-underserved-patients-through-every-heartbeat-matters-initiative-300266381.html
SOURCE Edwards Lifesciences Corporation